Investor · SALT LAKE CITY, UT

Michael M. Secora

Open Michael in the network graph →

Filings

9

SEC Form D

Connections

89

co-filers

Capital

$481.4M

across filings

Active

Jun 2019

to Jan 2021

Most-connected co-filers (89)

Meenakshi Ambardar · Grand Duchy of Luxembourg, Luxembourg6 shared Stephen M. Ward, Jr · Redwood City, CA4 shared Thierry Vandal · New York, NY4 shared Zachariah Jonasson · SAN MATEO, CA4 shared Dean Y. Li · Salt Lake City, UT4 shared Christopher C. Gibson · Salt Lake City, UT4 shared Ed M. Abbo · Redwood City, CA4 shared John Chen · San Mateo, CA4 shared Frank T. Levinson · San Mateo, CA4 shared Inga-Lill Carlberg · Stockholm, V74 shared Katja Mertes-Tegebauer · Grand Duchy of Luxembourg, Luxembourg4 shared Nobuyuki Kambe · San Mateo, CA4 shared Houman M. Behzadi · Redwood City, CA4 shared Jonathan Hallett · Atlanta, GA2 shared Victor A. Velculescu · Baltimore, MD2 shared Justin A. Klein · Baltimore, MD2 shared Richard Ruffer · New York, NY2 shared Zachary Bogue · Palo Alto, CA2 shared James A. Lafrance · Baltimore, MD2 shared Zavain P. Dar · MENLO PARK, CA2 shared John F. Pavlidis · Los Altos, CA2 shared Sam A. Anguioli · Baltimore, MD2 shared Luis A. Diaz, Jr · Baltimore, MD2 shared Brian R. Leighs · Wellington, Q22 shared

Recent filings (9)

Iambic Therapeutics, Inc.Nov 2025 · 31 co-filers$125.0M Iambic Therapeutics, Inc.Nov 2025 · 31 co-filers$125.0M Phoenix Venture Partners III LPJan 2021 · 13 co-filers RECURSION PHARMACEUTICALS, INC.Nov 2020 · 26 co-filers$245.9M Phoenix Venture Partners III LPSep 2020 · 13 co-filers RECURSION PHARMACEUTICALS, INC.Sep 2020 · 26 co-filers$235.5M Personal Genome Diagnostics Inc.May 2020 · 29 co-filers$3.5M Phoenix Venture Partners III LPNov 2019 · 14 co-filers Phoenix Venture Partners III LPJun 2019 · 14 co-filers Personal Genome Diagnostics Inc.Jun 2019 · 29 co-filers$20.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Michael in the interactive graph →